Aswath Damodaran
Avsnitt

Valeant: Damaged Goods or Deeply Discounted Drug Company?

Dela

I first valued Valeant in November 2015, after its fall from grace, and concluded that it was not a good investment then, but I did return to it in April 2016 and November 2016, and each time, found it under valued & bought the stock. In March 2017, my investment in the stock has lost 50% of its value. Part of me wants to go into denial (and not look at the stock), part of me wants to sell and never talk about it but I know that for my investment health, I need to take a look at the company and reassess whether it belongs in my portfolio at today's price. I attempt to do so, though it entirely possible that I am letting my delusions get the better of my good sense.Slides: http://www.stern.nyu.edu/~adamodar/pdfiles/blog/ValeatMarch2017.pdfBlog Post:Valuation: http://www.stern.nyu.edu/~adamodar/pc/blog/ValeantMarch2017.xls Learn more about your ad choices. Visit megaphone.fm/adchoices

Podden och tillhörande omslagsbild på den här sidan tillhör Aswath Damodaran. Innehållet i podden är skapat av Aswath Damodaran och inte av, eller tillsammans med, Poddtoppen.